Logo for Atea Pharmaceuticals Inc

Atea Pharmaceuticals Investor Relations Material

Latest events

Logo for Atea Pharmaceuticals Inc

Q3 2024

Atea Pharmaceuticals
Logo for Atea Pharmaceuticals

Q3 2024

7 Nov, 2024
Logo for Atea Pharmaceuticals

Q2 2024

7 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Atea Pharmaceuticals Inc

Access all reports
Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing antiviral therapies for the treatment of viral diseases. The company's research and development efforts primarily target diseases such as hepatitis C, dengue, and COVID-19. Atea leverages its expertise in nucleoside and nucleotide therapeutics to create treatments aimed at addressing unmet medical needs in the antiviral space. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.